To put this in perspective, the FDA approval of Ozempic was based on evidence from seven clinical trials with over 4,000 participants in 33 different countries
But GLP-1 medications, particularly the newer dual and triple agonists, are closing that gap with each generation
When it comes to weight management, Semaglutide and Liraglutide have emerged as two major players, both promising, yet distinct in their properties and uses
Our medical team offers free eligibility assessments to help determine if you qualify
GLP-1s Average weight loss is 15-20% in a year
We serve clients from Northridge CA, Los Angeles, CA, West LA, Porter Ranch CA, San Fernando, CA, Calabasas CA, Woodland Hills CA, Hidden Hills CA, Granada Hills, and BEYOND